Literature DB >> 11807400

Antioxidant Tempol enhances hypothermic cerebral preservation during prolonged cardiac arrest in dogs.

Wilhelm Behringer1, Peter Safar, Rainer Kentner, Xianren Wu, Valerian E Kagan, Ann Radovsky, Robert S B Clark, Patrick M Kochanek, Murugan Subramanian, Vladimir A Tyurin, Yulia Y Tyurina, Samuel A Tisherman.   

Abstract

The authors are systematically exploring pharmacologic preservation for temporarily unresuscitable exsanguination cardiac arrest in dogs. They hypothesized that the antioxidant Tempol improves cerebral outcome when added to aortic saline flush at the start of cardiac arrest. In study A, no drug (n = 8), Tempol 150 mg/kg (n = 4), or Tempol 300 mg/kg (n = 4) was added to 25 mL/kg saline flush at 24 degrees C (achieving mild cerebral hypothermia) at the start of 20-minute cardiac arrest. In study B, no drug (n = 8) or Tempol 300 mg/kg (n = 7) was added to 50 mL/kg saline flush at 2 degrees C (achieving moderate cerebral hypothermia) at the start of 40-minute cardiac arrest. Cardiac arrest was reversed with cardiopulmonary bypass. Mild hypothermia lasted for 12 hours, controlled ventilation was sustained to 24 hours, and intensive care was provided for up to 72 hours. In study A, overall performance category 1 or 2 (good outcome) was achieved in all eight dogs treated with Tempol compared with three of eight dogs in the control group ( P = 0.03). In study B, good outcome was achieved in all seven dogs treated with Tempol versus only two of 8 dogs in the control group ( P = 0.007). In both studies, neurologic deficit scores were significantly better in the Tempol group, but not total histologic damage scores. At 72 hours, electron paramagnetic resonance spectroscopy of Tempol revealed direct evidence for its presence in the brain. Single- and double-strand DNA damage, nitrotyrosine immunostaining, total antioxidant reserve, and ascorbate acid levels were similar between groups, and thiol levels were decreased after Tempol in study B. The authors conclude that when added to aortic saline flush at the start of prolonged cardiac arrest, the antioxidant Tempol can enhance mild or moderate hypothermic cerebral preservation in terms of improved functional outcome. The mechanisms involved in this beneficial effect need further clarification.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807400     DOI: 10.1097/00004647-200201000-00013

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  9 in total

1.  The combination of either tempol or FK506 with delayed hypothermia: implications for traumatically induced microvascular and axonal protection.

Authors:  Motoki Fujita; Yasutaka Oda; Enoch P Wei; John T Povlishock
Journal:  J Neurotrauma       Date:  2011-07       Impact factor: 5.269

2.  Endothelin activation of reactive oxygen species mediates stress-induced pressor response in Dahl salt-sensitive prehypertensive rats.

Authors:  Gerard D'Angelo; Analia S Loria; David M Pollock; Jennifer S Pollock
Journal:  Hypertension       Date:  2010-06-14       Impact factor: 10.190

3.  A high-throughput screening assay of ascorbate in brain samples.

Authors:  Natalia A Belikova; Ashley L Glumac; Valentyna Kapralova; Amin Cheikhi; Yulia Y Tyurina; Vincent A Vagni; Patrick M Kochanek; Valerian E Kagan; Hülya Bayir
Journal:  J Neurosci Methods       Date:  2011-08-09       Impact factor: 2.390

Review 4.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

5.  The mitochondria-targeted nitroxide JP4-039 augments potentially lethal irradiation damage repair.

Authors:  Malolan S Rajagopalan; Kanika Gupta; Michael W Epperly; Darcy Franicola; Xichen Zhang; Hong Wang; Hong Zhao; Vladimir A Tyurin; Joshua G Pierce; Valerian E Kagan; Peter Wipf; Anthony J Kanai; Joel S Greenberger
Journal:  In Vivo       Date:  2009 Sep-Oct       Impact factor: 2.155

Review 6.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

7.  Therapeutic hypothermia preserves antioxidant defenses after severe traumatic brain injury in infants and children.

Authors:  Hülya Bayir; P David Adelson; Stephen R Wisniewski; Paul Shore; YiChen Lai; Danielle Brown; Keri L Janesko-Feldman; Valerian E Kagan; Patrick M Kochanek
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

8.  Protection from systemic pyruvate at resuscitation in newborn lambs with asphyxial cardiac arrest.

Authors:  Vasantha H S Kumar; Sylvia Gugino; Lori Nielsen; Praveen Chandrasekharan; Carmon Koenigsknecht; Justin Helman; Satyan Lakshminrusimha
Journal:  Physiol Rep       Date:  2020-06

Review 9.  State-of-the-art methods for the treatment of severe hemorrhagic trauma: selective aortic arch perfusion and emergency preservation and resuscitation-what is next?

Authors:  Atsuyoshi Iida; Hiromichi Naito; Tsuyoshi Nojima; Tetsuya Yumoto; Taihei Yamada; Noritomo Fujisaki; Atsunori Nakao; Takeshi Mikane
Journal:  Acute Med Surg       Date:  2021-03-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.